Abpro Bio Statistics

Total Valuation

Abpro Bio has a market cap or net worth of KRW 86.83 billion. The enterprise value is 87.23 billion.

Market Cap	86.83B
Enterprise Value	87.23B

Important Dates

The last earnings date was Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Abpro Bio has 284.69 million shares outstanding. The number of shares has increased by 2.31% in one year.

Current Share Class	n/a
Shares Outstanding	284.69M
Shares Change (YoY)	+2.31%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	0.43%
Float	264.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.74
PB Ratio	0.80
P/TBV Ratio	0.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.58
EV / Sales	2.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.82

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.20.

Current Ratio	2.33
Quick Ratio	1.55
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-3.13

Financial Efficiency

Return on equity (ROE) is -13.57% and return on invested capital (ROIC) is -3.10%.

Return on Equity (ROE)	-13.57%
Return on Assets (ROA)	-2.89%
Return on Invested Capital (ROIC)	-3.10%
Return on Capital Employed (ROCE)	-5.44%
Revenue Per Employee	620.84M
Profits Per Employee	-306.46M
Employee Count	51
Asset Turnover	0.22
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.07% in the last 52 weeks. The beta is 1.26, so Abpro Bio's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-41.07%
50-Day Moving Average	353.68
200-Day Moving Average	446.27
Relative Strength Index (RSI)	41.47
Average Volume (20 Days)	960,063

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abpro Bio had revenue of KRW 31.66 billion and -15.63 billion in losses. Loss per share was -54.90.

Revenue	31.66B
Gross Profit	616.30M
Operating Income	-6.54B
Pretax Income	-16.06B
Net Income	-15.63B
EBITDA	-5.06B
EBIT	-6.54B
Loss Per Share	-54.90

Full Income Statement

Balance Sheet

The company has 21.66 billion in cash and 22.05 billion in debt, giving a net cash position of -395.59 million or -1.39 per share.

Cash & Cash Equivalents	21.66B
Total Debt	22.05B
Net Cash	-395.59M
Net Cash Per Share	-1.39
Equity (Book Value)	108.01B
Book Value Per Share	379.40
Working Capital	27.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.75 billion and capital expenditures -17.11 billion, giving a free cash flow of -22.86 billion.

Operating Cash Flow	-5.75B
Capital Expenditures	-17.11B
Free Cash Flow	-22.86B
FCF Per Share	-80.30

Full Cash Flow Statement

Margins

Gross margin is 1.95%, with operating and profit margins of -20.66% and -49.36%.

Gross Margin	1.95%
Operating Margin	-20.66%
Pretax Margin	-50.71%
Profit Margin	-49.36%
EBITDA Margin	-15.98%
EBIT Margin	-20.66%
FCF Margin	n/a

Dividends & Yields

Abpro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.31%
Shareholder Yield	-2.31%
Earnings Yield	-18.00%
FCF Yield	-26.33%

Stock Splits

The last stock split was on August 21, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Aug 21, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

Abpro Bio has an Altman Z-Score of 1.62. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.62
Piotroski F-Score	n/a